Akpinar, Ç. Et Al. 2024. Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions.. Clinical genitourinary cancer , vol.22, no.3 , 102071.

Akpinar, Ç., Oz, D., Oktar, A., Suer, E., Ozden, E., Haliloglu, N., ... Gulpinar, Ö.(2024). Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions.. Clinical genitourinary cancer , vol.22, no.3, 102071.

Akpinar, ÇAĞRI Et Al. "Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions.," Clinical genitourinary cancer , vol.22, no.3, 102071, 2024

Akpinar, ÇAĞRI Et Al. "Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions.." Clinical genitourinary cancer , vol.22, no.3, pp.102071, 2024

Akpinar, Ç. Et Al. (2024) . "Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions.." Clinical genitourinary cancer , vol.22, no.3, p.102071.

@article{article, author={ÇAĞRI AKPINAR Et Al. }, title={Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions.}, journal={Clinical genitourinary cancer}, year=2024, pages={102071} }